Mark Baldry - Net Worth and Insider Trading
Mark Baldry Net Worth
The estimated net worth of Mark Baldry is at least $19,766 dollars as of 2025-04-12. Mark Baldry is the Chief Commercial Officer of X4 Pharmaceuticals Inc and owns about 94,123 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $19,766. Details can be seen in Mark Baldry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Baldry has not made any transactions after 2025-01-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Baldry
Mark Baldry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Baldry owns 3 companies in total, including WAVE Life Sciences Ltd (WVE) , Amicus Therapeutics Inc (FOLD) , and X4 Pharmaceuticals Inc (XFOR) .
Click here to see the complete history of Mark Baldry’s form 4 insider trades.
Insider Ownership Summary of Mark Baldry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2019-08-05 | Chief Commerical Officer |
| FOLD | Amicus Therapeutics Inc | 2015-06-01 | VP Global Marketing |
| XFOR | X4 Pharmaceuticals Inc | 2025-01-24 | Chief Commercial Officer |
Mark Baldry Latest Holdings Summary
Mark Baldry currently owns a total of 1 stock. Mark Baldry owns 94,123 shares of X4 Pharmaceuticals Inc (XFOR) as of January 24, 2025, with a value of $19,766.
Latest Holdings of Mark Baldry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 2025-01-24 | 94,123 | 0.21 | 19,766 |
Holding Weightings of Mark Baldry
Mark Baldry Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Baldry has made a total of 4 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 29,159 shares on January 24, 2025, which brought Mark Baldry around $13,122.
Insider Trading History of Mark Baldry
- 1
Mark Baldry Trading Performance
GuruFocus tracks the stock performance after each of Mark Baldry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Baldry is 26.02%. GuruFocus also compares Mark Baldry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Baldry within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Baldry's insider trading performs compared to the benchmark.
Performance of Mark Baldry
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 66.1 |  | | | | |
| Relative Return to S&P 500(%) | 63.03 | | | | | |
Mark Baldry Ownership Network
Ownership Network List of Mark Baldry
Ownership Network Relation of Mark Baldry
Mark Baldry Owned Company Details
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Mark Baldry is the Chief Commerical Officer of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include director & See Remarks Paul Bolno , See Remarks Chris Francis , and 10 percent owner Plc Glaxosmithkline .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Mark Baldry made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 409,099 shares made by Paul Bolno , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 179,525 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 179,525 shares. During the past 18 months, 697,211 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,394,719 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
Mark Baldry Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Baldry. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Baldry's mailing address is: Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
